Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Employee Benefits topic
No spam. Unsubscribe anytime.
Putnam County approves one-year, $175,000 pilot to subsidize GLP‑1 medications for employees
Summary
After a heated debate over medical risks and open-ended costs, the Putnam County Board approved a one-year trial starting July 1 that caps county spending on GLP‑1 medication subsidies at $175,000 (July 1, 2026–June 30, 2027). The motion passed 4–1.
Get email alerts on the Employee Benefits topic
No spam. Unsubscribe anytime.
Putnam County commissioners voted to approve a one-year pilot program to subsidize GLP‑1 class medications for eligible county employees, imposing a $175,000 cap for the trial period beginning July 1, 2026.
The measure, discussed at length during the insurance committee item on the consent agenda, drew questions about clinical oversight, equity of access and potential fiscal exposure. Commissioners who supported the trial described it as a narrowly tailored first step to improve employee health and retention; those opposed warned the county was opening an open-ended liability without adequate guardrails.
“I think honestly at this point I'm going to probably go for this because I do believe it's a start, but we've got to be able to put a cap,” Commissioner Harvey said, urging a limit and monitoring plan. Commissioner Nebout likewise said the program could produce health and retention benefits while acknowledging it was open-ended without a cap.
Opponents raised safety and cost concerns. One commissioner described potential medical complications cited in the discussion — including gallbladder disease, pancreatitis and gastrointestinal problems — and questioned bypassing the county’s pharmacy benefit manager and health-plan processes to handle coverage through a separate program.
Board members agreed to amend the motion to a capped pilot: $175,000 for a one-year period (July 1, 2026–June 30, 2027), with staff and the insurance committee instructed to monitor enrollment, spending and available clinical metrics to help determine whether the program should continue and under what terms.
The motion passed 4–1.
What happens next: staff will work with the insurance committee to establish administrative details, reporting metrics and monitoring methods during the pilot year and will report back to the board on enrollment and fiscal impact.

